NHERF2
Na(+)/H(+) exchange regulatory cofactor NHE-RF2
Also known as: E3KARP, NHERF-2, NHRF2_HUMAN, SIP-1, SLC9A3R2, TKA-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15599
- Gene
- NHERF2
- Ensembl
- ENSG00000065054
- Chromosome
- 16
- Canonical length
- 337 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the NHERF family of PDZ scaffolding proteins. These proteins mediate many cellular processes by binding to and regulating the membrane expression and protein-protein interactions of membrane receptors and transport proteins. The encoded protein plays a role in intestinal sodium absorption by regulating the activity of the sodium/hydrogen exchanger 3, and may also regulate the cystic fibrosis transmembrane regulator (CFTR) ion channel. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
337 residues, UniProt reviewed canonical sequence.
>Q15599|NHERF2
1 MAAPEPLRPR LCRLVRGEQG YGFHLHGEKG RRGQFIRRVE PGSPAEAAAL RAGDRLVEVN
61 GVNVEGETHH QVVQRIKAVE GQTRLLVVDQ ETDEELRRRQ LTCTEEMAQR GLPPAHDPWE
121 PKPDWAHTGS HSSEAGKKDV SGPLRELRPR LCHLRKGPQG YGFNLHSDKS RPGQYIRSVD
181 PGSPAARSGL RAQDRLIEVN GQNVEGLRHA EVVASIKARE DEARLLVVDP ETDEHFKRLR
241 VTPTEEHVEG PLPSPVTNGT SPAQLNGGSA CSSRSDLPGS DKDTEDGSAW KQDPFQESGL
301 HLSPTAAEAK EKARAMRVNK RAPQMDWNRK REIFSNFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NHERF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 572 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 572 nTPM
- liver: 398 nTPM
- lung: 278 nTPM
- kidney: 240 nTPM
- adipose tissue: 220 nTPM
- thyroid gland: 182 nTPM
Single-cell type
- vascular endothelial cells: 487 nCPM
- lymphatic endothelial cells: 301 nCPM
- hepatocytes: 251 nCPM
- respiratory secretory cells: 222 nCPM
- breast lactating cells: 200 nCPM
- endometrial secretory cells: 138 nCPM
Immune cell
- myeloid DC: 3.9 nTPM
- plasmacytoid DC: 2.9 nTPM
- classical monocyte: 2.2 nTPM
- intermediate monocyte: 1.6 nTPM
- total PBMC: 0.7 nTPM
- gdT-cell: 0.5 nTPM
Brain region
- thalamus: 157 nTPM
- amygdala: 134 nTPM
- pons: 118 nTPM
- basal ganglia: 114 nTPM
- medulla oblongata: 111 nTPM
- midbrain: 108 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.04
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- beta-catenin binding
- cadherin binding
- identical protein binding
- phosphatase binding
- protein-membrane adaptor activity
- signaling receptor binding
- type 2 metabotropic glutamate receptor binding
- type 3 metabotropic glutamate receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NHERF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NHERF2 as an antibody target. Whether an autoantibody or antibody against NHERF2 could matter depends on whether native NHERF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NHERF2 is annotated at the cell surface, where native NHERF2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NHERF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...